Literature DB >> 6233441

31P-topical nuclear magnetic resonance (31P-TMR) studies of cardiotoxic effects of 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR).

H Tamatsu, M Nakazawa, S Imai, H Watari.   

Abstract

Using the 31P-topical nuclear magnetic resonance method (TMR), an attempt was made to determine the myocardial high-energy phosphate compounds (HEP) contents under in situ conditions in closed-chest animals, and the effects of opening the thorax on the myocardial energy metabolism were studied comparing the cardiotoxic effects of 5-fluorouracil (5-FU) in closed-chest and open-chest animals. It was found that the depletion of myocardial HEP produced by 5-FU was much more marked in open-chest animals than in closed-chest ones, indicating the necessity of conducting the experiments in closed-chest animals for the proper evaluation of the cardiotoxicity of certain types of compounds. Therefore, the cardiotoxicity of a prodrug of 5-FU was assessed in closed-chest animals, and it was found to be less cardiotoxic than 5-FU.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233441     DOI: 10.1254/jjp.34.375

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  8 in total

Review 1.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Noninvasive detection and monitoring of regional myocardial ischemia in situ using depth-resolved 31P NMR spectroscopy.

Authors:  P A Bottomley; R J Herfkens; L S Smith; S Brazzamano; R Blinder; L W Hedlund; J L Swain; R W Redington
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  5-Fluorouracil-induced acute reversible heart failure not explained by coronary spasms, myocarditis or takotsubo: lessons from MRI.

Authors:  Yama Fakhri; Morten Dalsgaard; Dorte Nielsen; Per Lav Madsen
Journal:  BMJ Case Rep       Date:  2016-06-01

4.  The pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancer.

Authors:  L J Schaaf; B R Dobbs; I R Edwards; D G Perrier
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?

Authors:  Jun Chong; Andrew Fw Ho; Jonathan Yap; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Cond Med       Date:  2019-10

Review 6.  A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.

Authors:  Anne Polk; Kirsten Vistisen; Merete Vaage-Nilsen; Dorte L Nielsen
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-04       Impact factor: 2.483

Review 7.  5-fluorouracil and cardiotoxicity: a review.

Authors:  Jaskanwal D Sara; Jasvinder Kaur; Ryan Khodadadi; Muneeb Rehman; Ronstan Lobo; Sakti Chakrabarti; Joerg Herrmann; Amir Lerman; Axel Grothey
Journal:  Ther Adv Med Oncol       Date:  2018-06-18       Impact factor: 8.168

Review 8.  New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging.

Authors:  Farah Cadour; Franck Thuny; Joevin Sourdon
Journal:  Front Cardiovasc Med       Date:  2022-02-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.